Medigold Life Sciences Private Limited
About Medigold Life Sciences Private Limited
Data last updated:
Medigold Life Sciences Private Limited is a private limited company based in Uruli Kanchan, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 October 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24233PN2014PTC152908. Its GSTIN is 27AAJCM4706H1ZE (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Jogindra Oamprakash Bhusari and Deepak Chandrakant Shewate.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Vilas Hole Complex First Floor 1002, Uruli Kanchan, Maharashtra, India – 412202.
As per the financials filed for FY 2021, the company reported a revenue of ₹2.41 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹67,396 (net margin 0.3%) and EBITDA of ₹3.64 Lakh (EBITDA margin 1.5%). Revenue has grown at a compounded annual rate (CAGR) of 151% over three years and 71% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Medigold Life Sciences Private Limited's registered office is in Uruli Kanchan, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressVilas Hole Complex First Floor 1002, Uruli Kanchan, Maharashtra, India – 412202
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medigold Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Medigold Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Medigold Life Sciences Private Limited, buy the company report.
Financials of Medigold Life Sciences Private Limited
FY 2021 filings availableMedigold Life Sciences Private Limited reported revenue of ₹2.41 Cr (up 705% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 71% over five years, including 705% growth in the latest year. EBITDA rose 416% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.64 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹67,396 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.5% | ||||
| Net Profit Margin | 0.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medigold Life Sciences Private Limited, buy the company report.
Board of directors of Medigold Life Sciences Private Limited
Medigold Life Sciences has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jogindra Oamprakash Bhusari | Director | 05 Aug 2019 | 7 Years 2 Months | Current |
| Deepak Chandrakant Shewate | Director | 22 Oct 2014 | 12 Years 0 Months | Current |
| Ravindra Chandrakant Shevate | Director | 22 Oct 2014 | 12 Years 0 Months | Current |
| Prashant Arvind Shevate | Director | 22 Oct 2014 | 12 Years 0 Months | Current |
Peer comparison
Medigold Life Sciences Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Grefuel Private Limited | ₹2.42 Cr (FY 2025) | 135.0% | Ankleshwar, Gujarat, India | |||
| Medirin Pharmaceuticals Private Limited | ₹2.42 Cr (FY 2025) | 1778.0% | Ambala Cantt, Haryana, India | |||
| Medigold Life Sciences Private Limitedthis company | ₹2.41 Cr (FY 2021) | ₹67,396 | 0.3% | 705.0% | Uruli Kanchan, Maharashtra, India | |
| Fourtrax Lifestyles Private Limited | ₹2.41 Cr (FY 2025) | 46.0% | Karnal, Haryana, India |
To see the full peer comparison of Medigold Life Sciences Private Limited, buy the company report.
Auditor
Medigold Life Sciences Private Limited is audited by A A PIMPALWADKAR & ASSOCIATES for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A A PIMPALWADKAR & ASSOCIATES | FY 2019 | 137721W |
Shareholding
The shareholding of Medigold Life Sciences Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Medigold Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Medigold Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medigold Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Medigold Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAJCM4706H1ZE | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medigold Life Sciences Private Limited, buy the company report.
Recent activity
Medigold Life Sciences Private Limited has 4 board changes on record since 2014: 4 appointments. The latest: Jogindra Oamprakash Bhusari was appointed as Director on 05 Aug 2019.
Frequently asked questions
Medigold Life Sciences is an active private limited company based in Uruli Kanchan, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 October 2014 (12+ years old) and is registered under CIN U24233PN2014PTC152908.
Medigold Life Sciences has 4 current directors:
- Jogindra Oamprakash Bhusari - Director
- Deepak Chandrakant Shewate - Director
- Ravindra Chandrakant Shevate - Director
- Prashant Arvind Shevate - Director
The latest financial statements of Medigold Life Sciences on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from 2015 are in the company report.
The GSTIN of Medigold Life Sciences is 27AAJCM4706H1ZE, registered in Maharashtra.
The CIN (Corporate Identification Number) of Medigold Life Sciences is U24233PN2014PTC152908. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medigold Life Sciences was incorporated on 22 October 2014, making it 12+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Medigold Life Sciences by revenue are Grefuel Private Limited, Medirin Pharmaceuticals Private Limited, Fourtrax Lifestyles Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Jogindra Oamprakash Bhusari was appointed as Director on 05 Aug 2019. Deepak Chandrakant Shewate was appointed as Director on 22 Oct 2014. Prashant Arvind Shevate was appointed as Director on 22 Oct 2014. Medigold Life Sciences has 4 board changes on record in total.
The registered office of Medigold Life Sciences is at Vilas Hole Complex First Floor 1002, Uruli Kanchan, Maharashtra, India – 412202.
Medigold Life Sciences operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Medigold Life Sciences is compliant as of 07 September 2026. The company is actively filing with the Registrar of Companies.